JUNKO TANAKA

Last Updated :2022/11/02

Affiliations, Positions
Medical Policy Office, Executive and Vice President
E-mail
jun-tanakahiroshima-u.ac.jp
Other Contact Details
1-2-3 Kasumi, Minami-ku, Hiroshima, Japan
TEL : (+81)82-257-5160 FAX : (+81)82-257-5164
Self-introduction
Graduate School of Medical Sciences, Epidemiology and Disease Control. In my laboratory, in order to prevent diseases and control countermeasures, I am conducting theoretical epidemiological research at the same time as laboratory research, and pursuing evidence that leads to policy proposals. We conduct NDB analysis, theoretical epidemiology, cost-effectiveness, medical statistics, simulation, viral gene analysis, immunoserology, standardization of measurement system, and epidemiology research related to blood business. In hepatitis virus research, we are conducting epidemiological surveys in Japan and overseas such as Cambodia and Brukina Faso to take measures against hepatitis and liver cancer. Epidemiological research on the new coronavirus has also begun. It is also important to develop human resources in the fields of epidemiology and disease control through the education of MPH School of Public Health and PhD.

Basic Information

Major Professional Backgrounds

  • 1981/11/24, 1987/03/31, Hiroshima University, Faculty of Medicine, Research Associate
  • 1990/04/01, 1995/07/31, Hiroshima University, Faculty of Medicine, Research Associate
  • 1990/04/01, 1995/07/31, Hiroshima University, Faculty of School Education, part-time lecturer
  • 1991/03/01, 1991/08/31, University of Minnesota, School of Public Health, Division of Biostatistics, Visiting Assistant Professor
  • 1995/08/01, 2002/03/31, Hiroshima University, Faculty of Medicine, Lecturer
  • 1995/08/01, 2000/03/31, Hiroshima University, Faculty of School Education, Lecturer
  • 2002/04/01, 2004/05/31, Hiroshima University, Graduate School of Biomedical Sciences, Lecturer
  • 2004/06/01, 2007/03/31, Hiroshima University, Graduate School of Biomedical Sciences, Assistant Professor
  • 2007/04/01, 2009/02/28, Hiroshima University, Graduate School of Biomedical Sciences, Associate Professor
  • 2009/03/01, Hiroshima University, Graduate School of Biomedical Sciences, Professor
  • 2012/11, Hiroshima University Project Research Center for Epidemiology and Prevention of Viral Hepatitis and Hepatocellular Carcinoma, Director
  • 2019/04/01, Project Research Center For epidemiological & mega-data analysis of New research area, Director
  • 2020/04/01, Health Policy Office, Executive Director / Executive Vice-President

Educational Backgrounds

  • Ochanomizu University, Faculty of Science, Mathmatics, Japan, 1976/04, 1980/03

Academic Degrees

  • Doctor of Philosophy in Medical Science, Hiroshima University

Educational Activity

  • [Bachelor Degree Program] School of Medicine : Program of Medicine : Medicine
  • [Master's Program] Graduate School of Biomedical and Health Sciences : Division of Integrated Health Sciences : Program of Public Health
  • [Master's Program] Graduate School of Biomedical and Health Sciences : Division of Integrated Health Sciences : Program of Biomedical Science
  • [Doctoral Program] Graduate School of Biomedical and Health Sciences : Division of Integrated Health Sciences : Program of Biomedical Science
  • [Doctoral Program] Graduate School of Biomedical and Health Sciences : Division of Biomedical Sciences : Program of Medicine

Research Fields

  • Medicine,dentistry, and pharmacy;Society medicine;Epidemiology and preventive medicine

Research Keywords

  • Epidemiology
  • Infectious Disease Control and Prevention
  • Theoretical Epidemiology
  • Hepatitis Virus
  • health check system
  • Seroepidemiology
  • Data Health

Affiliated Academic Societies

  • Japan Society of Public Health, 1986
  • Japanese Epidemiological Association, 1986
  • The Japan Society oh Hepatorogy, 1990
  • Japanese Society of Preventive Medicine, 2004
  • The Biometric Society of Japan, 2009
  • The Japanese Society for Hygiene, 2009
  • Japanese Cancer Association, 2011
  • Japan Society for Occupational Health, 2012
  • The Japanese Society of Gastrointestinal Cancer Screening, 2014

Educational Activity

Course in Charge

  1. 2022, Graduate Education (Master's Program) , First Semester, Research on Public Health (Epidemiology)
  2. 2022, Graduate Education (Master's Program) , Second Semester, Research on Public Health (Epidemiology)
  3. 2022, Graduate Education (Master's Program) , Second Semester, Research on Public Health (Epidemiology)
  4. 2022, Graduate Education (Master's Program) , First Semester, Research on Public Health (Biostatistics)
  5. 2022, Graduate Education (Master's Program) , Second Semester, Research on Public Health (Biostatistics)
  6. 2022, Graduate Education (Master's Program) , First Semester, Basic Epidemiology and Practice
  7. 2022, Graduate Education (Master's Program) , Second Semester, Basic and Advanced Training on Methodology for Clinical Research
  8. 2022, Graduate Education (Master's Program) , First Semester, Exercise and Seminar on Epidemiological Research and It's Analysis
  9. 2022, Graduate Education (Master's Program) , 3Term, Exercises and Seminar on Medical Statistics Using Statistical Software
  10. 2022, Graduate Education (Master's Program) , 1Term, Advanced Lecture on Preventive Medicine for Evidence-based Health Guidance A
  11. 2022, Graduate Education (Master's Program) , 3Term, Advanced Lecture on Preventive Medicine for Evidence-based Health Guidance B
  12. 2022, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar on Epidemiology,Infectious Disease Control and Prevention
  13. 2022, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar on Epidemiology,Infectious Disease Control and Prevention
  14. 2022, Graduate Education (Doctoral Program) , First Semester, Advanced Research on Epidemiology,Infectious Disease Control and Prevention
  15. 2022, Graduate Education (Doctoral Program) , Second Semester, Advanced Research on Epidemiology,Infectious Disease Control and Prevention
  16. 2022, Graduate Education (Doctoral Program) , Second Semester, Basic and Advanced Training on Methodology for Clinical Research
  17. 2022, Graduate Education (Master's Program) , 1Term, Academic approach to SDGs - A
  18. 2022, Graduate Education (Master's Program) , 2Term, Academic approach to SDGs - A[On-Demand]
  19. 2022, Graduate Education (Master's Program) , 4Term, Japanese Experience of Human Development-Culture, Education, and Health
  20. 2022, Graduate Education (Master's Program) , 4Term, Japanese Experience of Human Development-Culture, Education, and Health[On-Demand]
  21. 2022, Graduate Education (Master's Program) , 3Term, Data Literacy in Medicine
  22. 2022, Graduate Education (Doctoral Program) , 3Term, Utilization of data Literacy in Medicine[On-Demand]
  23. 2022, Undergraduate Education, Intensive, Social Medicine
  24. 2022, Undergraduate Education, 2Term, Introduction for medical research
  25. 2022, Undergraduate Education, 2Term, Outline of the Global Leadership Role
  26. 2022, Undergraduate Education, Intensive, Practice for medical research
  27. 2022, Graduate Education (Master's Program) , First Semester, Seminar
  28. 2022, Graduate Education (Master's Program) , Second Semester, Seminar
  29. 2022, Graduate Education (Master's Program) , First Semester, Research
  30. 2022, Graduate Education (Master's Program) , Second Semester, Research
  31. 2022, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar
  32. 2022, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar
  33. 2022, Graduate Education (Doctoral Program) , First Semester, Advanced Research
  34. 2022, Graduate Education (Doctoral Program) , Second Semester, Advanced Research
  35. 2022, Graduate Education (Master's Program) , 1Term, Seminar on Health Policy & Global Health
  36. 2022, Graduate Education (Master's Program) , 2Term, Basic Biostatistics and Basic Clinical Statistics

Award of Education

  1. 2021/12/09
  2. 2016/11/05
  3. 2018/11/01

Research Activities

Academic Papers

  1. Burden of cancer attributable to infection in Japan in 2015, Global Health and Medicine, 1(2), 63-69, 202112
  2. Identification of Aggravation-Predicting Gene Polymorphisms in Coronavirus Disease 2019 Patients Using a Candidate Gene Approach Associated With Multiple Phase Pathogenesis: A Study in a Japanese City of 1 Million People, Critical care explorations, 202111
  3. Autoantibodies neutralizing type I IFNs are present in similar to 4% of uninfected individuals over 70 years old and account for similar to 20% of COVID-19 deaths, Science immunology, 202108
  4. Effect of early rehabilitation on gait, wound and home discharge in lower extremity chronic wound patients: a Japanese multicenter retrospective study, The International Journal of Lower Extremity Wounds, 202108
  5. Serial changes in FIB-4 score and hepatocarcinogenesis in hepatitis B patients treated with or without nucleot(s)ide analogue therapy, GastroHep, 33, e513-e521, 2021
  6. Dried blood spot-based detection of serological profiles of hepatitis B and C infections and their prevalence in Cambodia, GastroHep, 3(4), 247, 202106
  7. Epidemiology of viral hepatitis C: Road to the elimination in Japan, Global Health and Medicine, 3(5), 262-269, 202110
  8. Epidemiological assessment of interventions to eliminate mother-to-child transmission of hepatitis B virus in japan, GastroHep, 3, 72-79, 202101
  9. Characteristics and prognosis of de novo hepatocellular carcinoma after sustained virologic response, Hepatology Communications, 5(7), 1290-1299, 202105
  10. The case for simplifying and using absolute targets for viral hepatitis elimination goals, JOURNAL OF VIRAL HEPATITIS, 28(1), 12-19, 202101
  11. Usefulness of serial FIB-4 score measurement for predicting the risk of hepatocarcinogenesis after hepatitis C virus eradication, EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 33, E513-E521, 202112
  12. Impact of switching to tenofovir alafenamide fumarate in patients with entecavir-treated chronic hepatitis B, EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 33, E898-E904, 202112
  13. Fatigue of workers judged from Subjective Symptoms, XI Asian Conference on Occupational Health, 346-351, 19850401
  14. A Recommendation Concerning Toxicity Test on Fish for Various Metals, Toxicology of Metals Clinical and Experimental Research, 133-134, 19870401
  15. The Effects of School Life on Smoking Behavior in Youth, 6Th World Conference on Smoking and Health, 561-563, 19870401
  16. A study on the Connected Items of smoking Habit in Youth and its Countermeasures., Hiroshima J. Med. Sci., 37(1), 37-40, 19880401
  17. Fatigue Caused by Visual Display Terminal Work ; An Experimental Investigation, Hiroshima J. Med. Sci., 38(2), 2, 19890401
  18. A Report of Fatigue in Japanese Contemporary Workers Based on Subjective Symptoms., Journal of UOEH, 11, 622-630, 19890401
  19. Toxicity to Medaka of Solutions of Fenitrothion degradated by strong Alkali, Environmental Pollution, 58, 35-42, 19890401
  20. Effects of Diphenylether Herbicide (CNP) on Mouse Fetuses, Hiroshima J. Med. Sci., 38(3), 125-130, 19890401
  21. The effects of Fenitrothion Emulsion (organic phosphorous pesticide) and Its Degraded Solution on Mice, Hiroshima J. Med. Sci., 38(4), 209-212, 19890401
  22. Toxicity to Fenitrothion Degradation to medaka(oryzias Latipes), Bulletin of Environmental Contamination and Toxicology, 44(2), 210-215, 19900401
  23. Comparison of HCV core antigen activity by ELISA and amount of HCV RNA by branched DNA assay, International Hepatology Communications, 2, 175-177, 19940401
  24. Ultrasound biomicroscopic study of ciliary body thickness after topical application of pharmacologic agents, American Journal of Ophthalmology, 121((3)), 319-321, 19960401
  25. Very low incidence rates of community-acquired hepatitis C virus infection in company employees, long-term inpatients, and blood donors in Japan, Journal of Epidemiology, 6(4), 198-203, 19960401
  26. Epidemiology of hepatitis C virus in Japan, Intervirology, 42, 153-158, 19990401
  27. Screening for gastroenterological malignancies in new and maintenance dialysis patients, Journal of Gastroenterology, 34, 35-40, 19990401
  28. Factors influencing arteriovenous fistula dysfunction in Japanese patients on chronic hemodialysis, The International Journal of Artificial Organs, 22(1), 14-17, 19990401
  29. High incidence of extrahepatic manifestations in an HCV hyperendemic area, HEPATOLOGY RESEARCH, 22(1), 27-36, 200201
  30. Effect of polymorphism of the endothelial nitric oxide synthase and apolipoprotein E genes on carotid atherosclerosis in hemodialysis patients, AMERICAN JOURNAL OF KIDNEY DISEASES, 41(4), 822-832, 200304
  31. ★, Natural histories of hepatitis C virus infection in men and women simulated by the Markov model, JOURNAL OF MEDICAL VIROLOGY, 70(3), 378-386, 200307
  32. Lack of epidemiological evidence for a role of resolved hepatitis B virus infection in hepatocarcinogenesis in patients infected with hepatitis C virus in Japan, INTERVIROLOGY, 46(3), 171-176, 2003
  33. Sex- and age-specific carriers of hepatitis B and C viruses in Japan estimated by the prevalence in the 3,485,648 first-time blood donors during 1995-2000, INTERVIROLOGY, 47(1), 32-40, 2004
  34. Titration of hepatitis C virus in chimpanzees for determining the copy number required for transmission, INTERVIROLOGY, 47(1), 57-64, 2004
  35. Association between ENOS gene polymorphism and cardiovascular events in nondiabetic hemodialysis patients; A prospective study, AMERICAN JOURNAL OF KIDNEY DISEASES, 44(1), 112-120, 200407
  36. Early dynamics of hepatitis C virus in the circulation of chimpanzees with experimental infection, INTERVIROLOGY, 48(2-3), 120-123, 2005
  37. National prevention of hepatocellular carcinoma in Japan based on epidemiology of hepatitis C virus infection in the general population, INTERVIROLOGY, 49(1-2), 7-17, 2005
  38. Hepatitis C virus infection in 2,744 hemodialysis patients followed regularly at nine centers in Hiroshima during November 1999 through February 2003, JOURNAL OF MEDICAL VIROLOGY, 76(4), 498-502, 200508
  39. Prediction of outcomes of assisted reproduction treatment using the calcium ionophore-induced acrosome reaction, HUMAN REPRODUCTION, 20(2), 469-475, 200502
  40. Hepatitis B Virus (HBV) screening strategy to ensure the safety of blood for transfusion through a combination of immunological testing and nucleic acid amplification testing - Japanese experience, JOURNAL OF CLINICAL VIROLOGY, 36, S56-S64, 200605
  41. Liver disease in hepatitis C virus carriers identified at blood donation and their outcomes with or without interferon treatment: Study on 1019 carriers followed for 5-10 years, HEPATOLOGY RESEARCH, 37(12), 994-1001, 2007
  42. Epidemiological survey of oral lichen planus among HCV-infected inhabitants in a town in Hiroshima Prefecture in Japan from 2000 to 2003, ONCOLOGY REPORTS, 18(5), 1177-1181, 200711
  43. ★, Incidence rates of hepatitis B and C virus infections among blood donors in Hiroshima, Japan, during 10 years from 1994 to 2004, INTERVIROLOGY, 51(1), 33-41, 2008
  44. Comparative study on the morphology and the composition of the otoliths in the teleosts, ACTA OTO-LARYNGOLOGICA, 128(8), 846-855, 2008
  45. Titration of Hepatitis B Virus Infectivity in the Sera of Pre-Acute and Late Acute Phases of HBV Infection: Transmission Experiments to Chimeric Mice With Human Liver Repopulated Hepatocytes, JOURNAL OF MEDICAL VIROLOGY, 80(12), 2064-2068, 2008
  46. Minimum infectious dose of hepatitis B virus in chimpanzees and difference in the dynamics of viremia between genotype A and genotype C, TRANSFUSION, 48(2), 286-294, 2008
  47. A novel hepatitis B virus surface antigen immunoassay as sensitive as hepatitis B virus nucleic acid testing in detecting early infection, TRANSFUSION, 49(3), 585-595, 2009
  48. Regular surveillance by imaging for early detection and better prognosis of hepatocellular carcinoma in patients infected with hepatitis C virus, JOURNAL OF GASTROENTEROLOGY, 45(1), 105-112, 2010
  49. Transcatheter chemoembolization for unresectable hepatocellular carcinoma and comparison of five staging systems, HEPATOLOGY RESEARCH, 40(11), 1082-1091, 2010
  50. Predictive value of tumor markers for hepatocarcinogenesis in patients with hepatitis C virus, JOURNAL OF GASTROENTEROLOGY, 46(4), 536-544, 2011
  51. Endogenous estrogen may prevent bone loss in postmenopausal hemodialysis patients throughout life, OSTEOPOROSIS INTERNATIONAL, 22(5), 1573-1579, 201105
  52. Evaluation of Rebound Tonometer for Measuring Intraocular Pressure at Deviated Angle and Position, CURRENT EYE RESEARCH, 36(5), 422-428, 2011
  53. ★, Total Numbers of Undiagnosed Carriers of Hepatitis C and B Viruses in Japan Estimated by Age- and Area-Specific Prevalence on the National Scale, INTERVIROLOGY, 54(4), 185-195, 2011
  54. Interferon Alone or Combined with Ribavirin for Acute Prolonged Infection with Hepatitis C Virus in Chimpanzees, INTERVIROLOGY, 54(4), 229-232, 2011
  55. Association of Serum Anti-Periodontal Pathogen Antibody with Ischemic Stroke, CEREBROVASCULAR DISEASES, 34(5-6), 385-392, 2012
  56. Morning blood pressure is useful for detection of left ventricular hypertrophy in hemodialysis patients, CLINICAL AND EXPERIMENTAL NEPHROLOGY, 16(6), 921-929, 2012
  57. Intraocular Pressure Measurement Using Rebound Tonometer for Deviated Angles and Positions in Human Eyes, CURRENT EYE RESEARCH, 37(2), 109-114, 2012
  58. Follow up of the 987 blood donors found with hepatitis C virus infection over 9-18 years, HEPATOLOGY RESEARCH, 42(7), 637-647, 2012
  59. Corneal displacement during tonometry with a noncontact tonometer, JAPANESE JOURNAL OF OPHTHALMOLOGY, 56(3), 273-279, 2012
  60. Comprehensive miRNA Expression Analysis in Peripheral Blood Can Diagnose Liver Disease, PLOS ONE, 7(10), 2012
  61. Improvement of glycated hemoglobin in Japanese subjects with type 2 diabetes by resolution of periodontal inflammation using adjunct topical antibiotics: Results from the Hiroshima Study, DIABETES RESEARCH AND CLINICAL PRACTICE, 100(1), 53-60, 2013
  62. Clinicopathological features of liver injury in patients with type 2 diabetes mellitus and comparative study of histologically proven nonalcoholic fatty liver diseases with or without type 2 diabetes mellitus, JOURNAL OF GASTROENTEROLOGY, 48(4), 515-525, 2013
  63. The Applicability of Ganglion Cell Complex Parameters Determined From SD-OCT Images to Detect Glaucomatous Eyes, JOURNAL OF GLAUCOMA, 22(9), 713-718, 201312
  64. Prognosis of chronic spontaneous urticaria in 117 patients not controlled by a standard dose of antihistamine, ALLERGY, 68(2), 229-235, 201302
  65. Characteristics of elderly hepatitis C virus-associated hepatocellular carcinoma patients, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 28(2), 357-364, 2013
  66. Effect of nucleos(t)ide analogue therapy on hepatocarcinogenesis in chronic hepatitis B patients: A propensity score analysis, JOURNAL OF HEPATOLOGY, 58(3), 427-433, 201303
  67. A tilting embryo culture system increases the number of high-grade human blastocysts with high implantation competence, REPRODUCTIVE BIOMEDICINE ONLINE, 26(3), 260-268, 2013
  68. Report from a Viral Hepatitis Policy Forum on implementing the WHO framework for global action on viral hepatitis in North Asia, JOURNAL OF HEPATOLOGY, 59(5), 1073-1080, 201311
  69. Evaluation of strategies for control and prevention of pandemic influenza (H1N1pdm) in Japanese children attending school in rural town Simulation using mathematical models, 60(4), 204-211, 2013
  70. Inner retinal layer comparisons of eyes with exudative age-related macular degeneration and eyes with age-related macular degeneration and glaucoma, GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 252(4), 563-570, 2014
  71. Using the Early Postoperative Intraocular Pressure to Predict Pressure Control After a Trabeculectomy, JOURNAL OF GLAUCOMA, 23(6), 410-414, 2014
  72. Changes in hepatitis C virus genotype distribution in Japan, EPIDEMIOLOGY AND INFECTION, 142(12), 2624-2628, 201412
  73. Quantitative Effect of Natural Killer-Cell Licensing on Hepatocellular Carcinoma Recurrence after Curative Hepatectomy, CANCER IMMUNOLOGY RESEARCH, 2(12), 1142-1147, 2014
  74. Width of abnormal ganglion cell complex area determined using optical coherence tomography to predict glaucoma, JAPANESE JOURNAL OF OPHTHALMOLOGY, 58(1), 47-55, 2014
  75. Validation and limitation of age-period-cohort model in simulating mortality due to hepatocellular carcinoma from 1940 to 2010 in Japan, HEPATOLOGY RESEARCH, 44(7), 713-719, 2014
  76. High-sensitivity Lens culinaris agglutinin-reactive alpha-fetoprotein assay predicts early detection of hepatocellular carcinoma, JOURNAL OF GASTROENTEROLOGY, 49(3), 555-563, 201403
  77. ★, Estimating numbers of persons with persistent hepatitis B virus infection transmitted vertically and horizontally in the birth cohort during 1950-1985 in Japan, HEPATOLOGY RESEARCH, 44(10), E181-E188, 2014
  78. Cost-effectiveness of the introduction of low-dose CT screening in Japanese Smokers aged 55 to 74 years old, Hiroshima Journal of Medical Sciences, 63(1-3), 13-22, 2014
  79. Validation of Rapid Point-of-Care (POC) Tests for Detection of Hepatitis B Surface Antigen in Field and Laboratory Settings in the Gambia, Western Africa, JOURNAL OF CLINICAL MICROBIOLOGY, 53(4), 1156-1163, 2015
  80. Seroprevalence, genotypic distribution and potential risk factors of hepatitis B and C virus infections among adults in Siem Reap, Cambodia, HEPATOLOGY RESEARCH, 45(4), 480-487, 2015
  81. Effect of increasing respiratory rate on airway resistance and reactance in COPD patients, RESPIROLOGY, 20(1), 87-94, 201501
  82. High prevalences of hepatitis B and C virus infections among adults living in Binh Thuan province, Vietnam, HEPATOLOGY RESEARCH, 45(3), 259-268, 2015
  83. Estimated numbers of patients with liver disease related to hepatitis B or C virus infection based on the database reconstructed from medical claims from 2008 to 2010 in Japan, HEPATOLOGY RESEARCH, 45(12), 1228-1240, 2015
  84. Hepatitis B virus infection in hemodialysis patients in Japan: Prevalence, incidence and occult hepatitis B virus infection, HEPATOLOGY RESEARCH, 45(12), 1211-1219, 2015
  85. The association of hepatitis C virus infection with the prognosis of chronic hemodialysis patients: A retrospective study of 3,064 patients between 1999 and 2010, JOURNAL OF MEDICAL VIROLOGY, 87(9), 1558-1564, 2015
  86. Hepatitis E Virus in Cambodia: Prevalence among the General Population and Complete Genome Sequence of Genotype 4, PLOS ONE, 10(8), 2015
  87. Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 3, JOURNAL OF VIRAL HEPATITIS, 22, 4-20, 201512
  88. The present and future disease burden of hepatitis C virus infections with today's treatment paradigm - volume 3, JOURNAL OF VIRAL HEPATITIS, 22, 21-41, 201512
  89. Strategies to manage hepatitis C virus infection disease burden - volume 3, JOURNAL OF VIRAL HEPATITIS, 22, 42-65, 201512
  90. Intraocular pressure readings obtained through soft contact lenses using four types of tonometer, CLINICAL OPHTHALMOLOGY, 9, 1875-1881, 2015
  91. Sustained virological response to antiviral therapy improves survival rate in patients with recurrent hepatitis C virus infection after liver transplantation, HEPATOLOGY RESEARCH, 45(11), 1047-1054, 2015
  92. Effect of tenofovir disoproxil fumarate on drug-resistant HBV clones, JOURNAL OF INFECTION, 72(1), 91-102, 2016
  93. Hypothalamic-pituitary-adrenal axis activity is associated with the prevalence of chronic kidney disease in diabetic patients, ENDOCRINE JOURNAL, 63(2), 119-126, 20160220
  94. Long-term prognosis of patients with chronic hepatitis C who did not receive interferon-based therapy: causes of death and analysis based on the FIB-4 index, JOURNAL OF GASTROENTEROLOGY, 51(4), 380-389, 201604
  95. Follow-up study of the regional quota system of Japanese medical schools and prefecture scholarship programmes: a study protocol, BMJ OPEN, 6(4), 2016
  96. Different sensitivity of rituximab-treatment to B-cells between ABO-incompatible kidney and liver transplantation, HUMAN IMMUNOLOGY, 77(6), 456-463, 201606
  97. HBcrAg predicts hepatocellular carcinoma development: An analysis using time-dependent receiver operating characteristics, JOURNAL OF HEPATOLOGY, 65(1), 48-56, 201607
  98. Y Viral eradication reduces all-cause mortality in patients with chronic hepatitis C virus infection: a propensity score analysis, LIVER INTERNATIONAL, 36(6), 817-826, 201606
  99. Key role of heat shock protein 90 in leptin-induced STAT3 activation and feeding regulation, BRITISH JOURNAL OF PHARMACOLOGY, 173(15), 2434-2445, 201608
  100. Reproducibility of optic disk evaluation in supine subjects with a Heidelberg Retina Tomograph II laser tomographic scanner, CLINICAL OPHTHALMOLOGY, 10, 1617-1622, 2016
  101. Systematic review and, meta-analysis of hepatitis C virus infection in the Democratic Republic of Congo, PUBLIC HEALTH, 139, 13-21, 201610
  102. ★, Predicting future blood supply and demand in Japan with a Markov model: application to the sex- and age-specific probability of blood donation, TRANSFUSION, 56(11), 2750-2759, 201611
  103. High Vaccination Coverage among Children during Influenza A(H1N1)pdm09 as a Potential Factor of Herd Immunity, INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 13(10), 201610
  104. Impact of FIB-4 index on hepatocellular carcinoma incidence during nucleos(t)ide analogue therapy in patients with chronic hepatitis B: An analysis using time-dependent receiver operating characteristic, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 32(2), 451-458, 201702
  105. Viral eradication reduces all-cause mortality, including nonliver-related disease, in patients with progressive hepatitis C virus-related fibrosis, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 32(3), 687-694, 201703
  106. Mustard gas exposure and mortality among retired workers at a poisonous gas factory in Japan: a 57-year follow-up cohort study, OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 74(5), 321-327, 201705
  107. A comparison of clinicopathological features and prognosis in prostate cancer between atomic bomb survivors and control patients, ONCOLOGY LETTERS, 14(1), 299-305, 201707
  108. Clustering infection of hepatitis B virus genotype B4 among residents in Vietnam, and its genomic characters both intra- and extra-family, PLOS ONE, 12(7), 20170728
  109. Barrier assessment in establishing comprehensive client-level coordination for treatment and medical welfare of people living with hemophilia and HIV/AIDS in Japan, HAEMOPHILIA, 20, 164-164, 2014
  110. Post-treatment levels of -fetoprotein predict long-term hepatocellular carcinoma development after sustained virological response in patients with hepatitis C, HEPATOLOGY RESEARCH, 47(10), 1021-1031, 201709
  111. A multi-institutional feasibility study of S-1/oxaliplatin plus bevacizumab in patients with advanced/metastatic colorectal cancer: the HiSCO-02 prospective phase II study, SPRINGERPLUS, 5, 20161018
  112. Reduced prevalence of hepatitis B surface antigen positivity among pregnant women born after the national implementation of immunoprophylaxis for babies born to hepatitis B virus-carrier mothers in Japan, HEPATOLOGY RESEARCH, 47(12), 1329-1334, 201711
  113. Differences in the impact of prognostic factors for hepatocellular carcinoma over time, CANCER SCIENCE, 108(12), 2438-2444, 201712
  114. A seroepidemiological survey of the effect of hepatitis B vaccine and hepatitis B and C virus infections among elementary school students in Siem Reap province, Cambodia, HEPATOLOGY RESEARCH, 48(3), E172-E182, 201802
  115. Pilot study for hepatitis virus screening among employees as an effective approach to encourage employees who screened positive to receive medical care in Japan, HEPATOLOGY RESEARCH, 48(3), E291-E302, 201802
  116. Viral eradication reduces both liver stiffness and steatosis in patients with chronic hepatitis C virus infection who received direct-acting anti-viral therapy, ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 47(7), 1012-1022, 201804
  117. ★, Incidence and risk factors of colorectal cancer based on 56324 health checkups: A 7-year retrospective cohort study, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 33(4), 855-862, 201804
  118. Hepatitis B virus core-related antigen levels predict progression to liver cirrhosis in hepatitis B carriers, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 33(4), 918-925, 201804
  119. Efficacy of cognitive-behavioral therapy for patients with temporomandibular disorder pain-systematic review of previous reports, INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 11(2), 500-509, 2018
  120. ★, Trends in the total numbers of HBV and HCV carriers in Japan from 2000 to 2011, JOURNAL OF VIRAL HEPATITIS, 25(4), 363-372, 201804
  121. Soft silicone foam dressing is more effective than polyurethane film dressing for preventing intraoperatively acquired pressure ulcers in spinal surgery patients: the Border Operating room Spinal Surgery (BOSS) trial in Japan, INTERNATIONAL WOUND JOURNAL, 15(2), 188-197, 201804
  122. High prevalence of hepatitis B infections in Burkina Faso (1996-2017): a systematic review with meta-analysis of epidemiological studies, BMC PUBLIC HEALTH, 18, 20180425
  123. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study, LANCET GASTROENTEROLOGY & HEPATOLOGY, 2(3), 161-176, 201703
  124. Cost-effectiveness analyses of anti-hepatitis C virus treatments using quality of life scoring among patients with chronic liver disease in Hiroshima prefecture, Japan, HEPATOLOGY RESEARCH, 48(7), 509-520, 201806
  125. Progression of liver fibrosis is associated with non-liver-related mortality in patients with nonalcoholic fatty liver disease, Hepatology Communications, 1(i9), 899-910, 2017
  126. Impact of previously cured hepatocellular carcinoma (HCC) on new development of HCC after eradication of hepatitis C infection with non-interferon-based treatments, ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 48(6), 664-670, 201809
  127. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030, JOURNAL OF HEPATOLOGY, 69(4), 896-904, 201810
  128. Effect of bevacizumab plus XELOX (CapeOX) chemotherapy on liver natural killer cell activity in colorectal cancer with resectable liver metastasis, ANNALS OF GASTROENTEROLOGICAL SURGERY, 2(5), 383-393, 201809
  129. ★, Natural course of persistent hepatitis B virus infection in hepatitis B e antigen-positive and hepatitis B e antigen-negative cohorts in Japan based on the Markov model, JOURNAL OF MEDICAL VIROLOGY, 90(12), 1800-1813, 201812
  130. Cytokine and chemokine signatures associated with hepatitis B surface antigen loss in hepatitis B patients, JCI INSIGHT, 3(20), 20181018
  131. Long-term natural history of liver disease in patients with chronic hepatitis B virus infection: an analysis using the Markov chain model, JOURNAL OF GASTROENTEROLOGY, 53(11), 1196-1205, 201811
  132. Impact of hepatocellular carcinoma aetiology and liver function on the benefit of surveillance: A novel approach for the adjustment of lead-time bias, LIVER INTERNATIONAL, 38(12), 2260-2268, 201812
  133. ★, Incidence rates of hepatitis C virus infection among blood donors in Japan: a nationwide retrospective cohort study, TRANSFUSION, 58(12), 2880-2885, 201812
  134. New Diagnostic Criteria for the Localization of Insulinomas with the Selective Arterial Calcium Injection Test: Decision Tree Analysis, JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 29(12), 1749-1753, 201812
  135. ★, Acquisition rate of antibody to hepatitis B surface antigen among medical and dental students in Japan after three-dose hepatitis B vaccination, VACCINE, 37(1), 145-151, 20190103
  136. ★, Very low prevalence of anti-HAV in Japan: high potential for future outbreak, SCIENTIFIC REPORTS, 9, 20190206
  137. The impact of HCV eradication by direct-acting antivirals on the transition of precancerous hepatic nodules to HCC: A prospective observational study, LIVER INTERNATIONAL, 39(3), 448-454, 201903
  138. Levocarnitine Use Is Associated With Improvement in Sarcopenia in Patients With Liver Cirrhosis, HEPATOLOGY COMMUNICATIONS, 3(3), 348-355, 201903
  139. ★, Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study, LANCET GASTROENTEROLOGY & HEPATOLOGY, 3(6), 383-403, 201806
  140. Progression of Liver Fibrosis Is Associated With Non-Liver-Related Mortality in Patients With Nonalcoholic Fatty Liver Disease, HEPATOLOGY COMMUNICATIONS, 1(9), 899-910, 201711
  141. ★, A Questionnaire Survey on the Sequence of Events Prior to Undergoing Colonoscopy: The Influence of the Behavioral Response after a Fecal Occult Blood Test on the Early Detection of Colorectal Cancer, INTERNAL MEDICINE, 58(11), 1541-1547, 2019
  142. Impact of albumin-bilirubin grade on survival in patients with hepatocellular carcinoma who received sorafenib: An analysis using time-dependent receiver operating characteristic, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 34(6), 1066-1073, 201906
  143. ★, Natural history of liver-related disease in patients with chronic hepatitis C virus infection: An analysis using a Markov chain model, JOURNAL OF MEDICAL VIROLOGY, 91(10), 1837-1844, 201910
  144. The course of elderly patients with persistent hepatitis C virus infection without hepatocellular carcinoma, JOURNAL OF GASTROENTEROLOGY, 54(9), 829-836, 201909
  145. ★, High possibility of hepatocarcinogenesis in HBV genotype C1 infected Cambodians is indicated by 340 HBV C1 full-genomes analysis from GenBank, SCIENTIFIC REPORTS, 9, 20190821
  146. The Pilot Study for Health Check-Ups System at Elementary School in Cambodia, Hiroshima Journal of Medical Sciences, 67(3), 88-92, 2018
  147. ★, Countermeasures against viral hepatitis B and C in Japan: An epidemiological point of view, HEPATOLOGY RESEARCH, 49(9), 990-1002, 201909
  148. Serum milk fat globule-EGF factor 8 (MFG-E8) as a diagnostic and prognostic biomarker in patients with hepatocellular carcinoma, SCIENTIFIC REPORTS, 9, 20191031
  149. Alteration of gut microbiota by a Westernized lifestyle and its correlation with insulin resistance in non-diabetic Japanese men, JOURNAL OF DIABETES INVESTIGATION, 10(6), 1463-1470, 201911
  150. The emergence of non-hypervascular hypointense nodules on enhanced MRI in patients with chronic hepatitis C, ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 50(11-12), 1232-1238, 201912
  151. Comparison of new prognostic systems for patients with resectable hepatocellular carcinoma: Albumin-Bilirubin grade and Albumin-Indocyanine Green Evaluation grade, HEPATOLOGY RESEARCH, 49(10), 1218-1226, 201910
  152. Type 2 diabetes mellitus: A risk factor for progression of liver fibrosis in middle-aged patients with non-alcoholic fatty liver disease, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 34(11), 2011-2018, 201911
  153. Long-term prognosis of liver disease in patients with chronic hepatitis B virus infection receiving nucleos(t)ide analogue therapy: an analysis using a Markov chain model, EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 31(11), 1452-1459, 201911
  154. Liver stiffness does not affect ultrasound-guided attenuation coefficient measurement in the evaluation of hepatic steatosis, HEPATOLOGY RESEARCH, 50(2), 190-198, 202002
  155. The changing epidemiology of hepatitis B and C infections in Nanoro, rural Burkina Faso: a random sampling survey, BMC INFECTIOUS DISEASES, 20(1), 20200115
  156. Existence of hepatitis B virus surface protein mutations and other variants: demand for hepatitis B infection control in Cambodia, BMC INFECTIOUS DISEASES, 20(1), 20200425
  157. Hepatitis B surface antigen seroprevalence among pre- and post-vaccine cohorts in Cambodia, 2017, VACCINE, 37(35), 5059-5066, 20190814
  158. Diagnostic performance of peripheral leukocyte telomere G-tail length for detecting breast cancer, CANCER SCIENCE, 111(5), 1856-1861, 202005
  159. Meta-regression analysis of sex-and birth year-specific prevalence of HBsAg and anti-HCV among un-.diagnosed Japanese: Data from the first-time blood donors, periodical health checkup, and the comprehensive health checkup with lifestyle education, Journal of Epidemiology, 2019
  160. Evaluation of the efficiency of dried blood spot-based measurement of hepatitis B and hepatitis C virus seromarkers, Scientific Reports, 10(1), 3857-3857, 2019
  161. Comparison of liver disease state progression in patients with eradication of versus persistent infection with hepatitis C virus: Markov chain analysis, JOURNAL OF VIRAL HEPATITIS, 28(3), 538-547, 202103
  162. Long-term prognosis with or without nucleot(s)ide analogue therapy in hepatitis B virus-related decompensated cirrhosis, JOURNAL OF VIRAL HEPATITIS, 28(3), 508-516, 202103
  163. A novel model for predicting posthepatectomy liver failure based on liver function and degree of liver resection in patients with hepatocellular carcinoma, HPB, 23(1), 134-143, 202101
  164. Molecular characterization and the mutation pattern of SARS-CoV-2 during first and second wave outbreaks in Hiroshima, Japan, PLOS ONE, 16(2), 20210205
  165. Screening for M-proteinemia consisting of monoclonal gammopathy of undetermined significance and multiple myeloma for 30 years among atomic bomb survivors in Hiroshima, INTERNATIONAL JOURNAL OF HEMATOLOGY, 113(4), 576-585, 202104
  166. Prevalence of total hepatitis A antibody among 5 to 7 years old children and their mothers in Cambodia, SCIENTIFIC REPORTS, 11(1), 20210226
  167. Applicability of APRI and FIB-4 as a transition indicator of liver fibrosis in patients with chronic viral hepatitis, JOURNAL OF GASTROENTEROLOGY, 56(5), 470-478, 202105
  168. Comparison of the impact of tenofovir alafenamide and entecavir on declines of hepatitis B surface antigen levels, EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 32(2), 255-260, 202102
  169. Comparison of the Prognosis of Decompensated Cirrhosis in Patients with and Without Eradication of Hepatitis C Virus, INFECTIOUS DISEASES AND THERAPY, 10(2), 1001-1013, 202106
  170. Pretreatment non-hypervascular hypointense nodules on Gd-EOB-DTPA-enhanced MRI as a predictor of hepatocellular carcinoma development after sustained virologic response in HCV infection, ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 53(12), 1309-1316, 202106
  171. A multi-institutional survey of the quality of life after treatment for uterine cervical cancer: a comparison between radical radiotherapy and surgery in Japan, JOURNAL OF RADIATION RESEARCH, 62(2), 269-284, 202103
  172. Prediction of Hepatocellular Carcinoma by Liver Stiffness Measurements Using Magnetic Resonance Elastography After Eradicating Hepatitis C Virus, CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 12(4), 202104
  173. Long-term outcomes of viral eradication in patients with hepatitis C virus infection and mild hepatic fibrosis, JOURNAL OF VIRAL HEPATITIS, 28(9), 1293-1303, 202109
  174. Impact of Immune Reconstitution-Induced Hepatic Flare on Hepatitis B Surface Antigen Loss in Hepatitis B Virus/Human Immunodeficiency Virus-1 Coinfected Patients, JOURNAL OF INFECTIOUS DISEASES, 223(12), 2080-2089, 20210615
  175. The Association between Wearing a Mask and COVID-19, INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 18(17), 202109
  176. Utility of serological tumor biomarkers for surveillance of hepatocellular carcinoma in patients undergoing dialysis, NEPHROLOGY DIALYSIS TRANSPLANTATION, 36(6), 1097-1103, 202106
  177. Lack of hepatitis C virus reinfection in lifetime of Japanese general population with previous hepatitis C virus (HCV) infection successfully treated with anti-HCV therapy, JOURNAL OF INFECTION AND CHEMOTHERAPY, 27(11), 1674-1675, 202111
  178. A multicenter randomized controlled trial comparing administration of antithrombin III after liver resection (HiSCO-05 trial), SURGERY, 170(4), 1140-1150, 202110
  179. Epidemiologic profile of hepatitis C virus infection and genotype distribution in Burkina Faso: a systematic review with meta-analysis, BMC INFECTIOUS DISEASES, 21(1), 20211101
  180. Outcomes of Patients Who Undergo Transfusion of Fresh Frozen Plasma: A Prospective, Observational, Multicentre Cohort Study in Hiroshima, Japan, JOURNAL OF BLOOD MEDICINE, 12, 965-973, 2021
  181. Relationship between drinking frequency and fatty liver prevalence or incidence in Japanese undergoing health checkup in 2008-2019, LIVER INTERNATIONAL, 41(12), 2914-2923, 202112

Invited Lecture, Oral Presentation, Poster Presentation

  1. Session 1 Introduction: Actions in Hepatitis Prevention, Control and Advocacy to Prevent Liver Cancer (Moderators), Tanaka J, APASL-CEVHAP-WHO Public Health Symposium "Detect Early - Prevent Liver Cancer and Death" Key Issues for Hepatitis Advocacy as we work towards elimination in 2030, 2022/03/31, With Invitation, English
  2. Panel Discussion /Q&A(LIVE) What is role of clinical community? Japan: Evolution of attributable risk from infection to lifestyle; UHC treatment towards elimination of HCV -- what was the approach taken, Tanaka J, APASL-CEVHAP-WHO Public Health Symposium "Detect Early - Prevent Liver Cancer and Death" Key Issues for Hepatitis Advocacy as we work towards elimination in 2030, 2022/03/31, With Invitation, English
  3. Assessment of COVID-19 Response on Hepatitis B virus and hepatitis C virus prevention and treatment from nationwide survey in Japan, Md. Shafiqul Hossain, APASL(Asian Pacific Association for the Study of the Liver-Single Topic Conference 2022), 2022/03/31, Without Invitation, English
  4. Prevalence and genotype distribution of hepatitis B among pregnant women in Siem Reap province, Cambodia, E Bunthen, APASL(Asian Pacific Association for the Study of the Liver-Single Topic Conference 2022), 2022/03/31, Without Invitation, English
  5. Genotype distribution and mutation pattern linked to liver disease progression among chronic hepatitis B carriers in Goto Islands, Japan, Ouoba S, APASL(Asian Pacific Association for the Study of the Liver-Single Topic Conference 2022), 2022/03/31, Without Invitation, English
  6. HCC in Japan, Epidemiology, Tanaka J, APASL Oncology 2021, 2021/12/17, With Invitation, English
  7. Prevalence of fatty liver and advanced fibrosis by using ultrasonography and fibroscan in a random sample of the general population, Sugiyama A, AASLD The Liver Meeting 2021, 2021/11/15, Without Invitation, English
  8. Total number of HCV patients treated with DAAs in Japan using IQVIA database from 2014 to 2019, Ohisa M, AASLD The Liver Meeting 2021, 2021/11/15, Without Invitation, English
  9. Epidemiology of NAFLD in Japan: A Nationwide Population-based Study, Tanaka J, AASLD The Liver Meeting 2021 AASLD/Japan Society of Hepatology Joint Symposium on Demand, 2021/11/08, With Invitation, English
  10. Simulation for burden of hepatitis B and C in Japan until 2030, under the appearance of drug curable HBV, Akita T, JSH International Liver Conference 2021 Pioneering New Frontier in Liver Cancer -From Bench to Bedside and Beyond0, 2021/10/03, Without Invitation, English
  11. Sero-epidemiological evaluation for micro-elimination of viral hepatitis in three model areas in Hiroshima, Ko Ko, JSH International Liver Conference 2021 Pioneering New Frontier in Liver Cancer -From Bench to Bedside and Beyond0, 2021/10/03, Without Invitation, English
  12. Liver biopsy implementation rate for diagnosis of NASH in Japan - analysis for big data of health insurance claims -, Sugiyama A, JSH International Liver Conference 2021 Pioneering New Frontier in Liver Cancer -From Bench to Bedside and Beyond0, 2021/10/03, Without Invitation, English
  13. The relationship between the frequency of drinking and incidence of fatty liver in Japanese cohort undergoing health checkups during the period 2008-2019 , Sugiyama A, EASL Digital NAFLD Summit 2021, 2021/09/16, Without Invitation, English
  14. Modeling Disease Burden of Nonalcoholic Fatty Liver Disease (NAFLD) in Japan, Tanaka J, 56th the international Liver Congress 2021(EASL), 2021/06/23, Without Invitation, English
  15. Public Health 3 "Public Policy": Strategy and Implementation of Viral Hepatitis Elimination in Japan, Tanaka J, ISVHLD GHS 2021 "Evolution and Revolution of Viral Heapatitis and Liver Disease", 2021/06/19, With Invitation, English
  16. Epidemiological research and countering COVID-19-Hiroshima experience,Japan, Tanaka J, COVID-19 INTERNATIONAL CONGRESS Health care during the pandemic experience and achievements in the fight against COVID-19, 2021/06/03, With Invitation, English
  17. Epidemiological Assessment of the interventions for elimination of mother-to-child transmission of hepatitis B virus in Japan, Tanaka J, Sugiyama A, Ko K, Yamamoto C, AASLD The Liver Meeting 2019, 2019/11/09, Without Invitation, English
  18. Epidemiological trends in viral hepatitis B and C in Japan, Tanaka J, HEPATITIS CLINICAL FORUM, 2019/10/29, With Invitation, Japanese
  19. Epiemiology of viral hepatitis, Tanaka J, 5th Scietific and Practical conference on the problem of infectious Diseases, 2019/09/05, With Invitation, English
  20. Epidemiology of hepatitis B virus in Japan and Asia, Tanaka J, 2018/11/01, Without Invitation, Japanese
  21. Epidemiology of HBV and HCV infections in Japan from the viewpoint of viral hepatitis eradication, Tanaka J, The 3rd MYONGJI INTERNATIONAL LIVER SYMPOSIUM, 2018/09/07, With Invitation, English
  22. The sero-epidemiological study on the prevalence of hepatitis B among children and mother in Cambodia., Tanaka J, VHPB (Viral Hepatitis Prevention Board)ASIA MEETING Prevention and control of hepatitis B with combined vaccines, and timely birth dose vaccination, 2018/07/25, With Invitation, English
  23. Pathway from the Epidemiological Point of View; Moving towards the Elimination of HBV & HCV in Japan, Tanaka J, 2018 APASL Single Topic Conference on Hepatitis B Virus Taipei, 2018/06/23, With Invitation, English, Taipei,Taiwan
  24. (Moderator) Plenary Session(I):Epidemiology Impacts of secondary and TertiaryPrevention in Choronic Hepatitis B Elimination, Tanaka J, 2018/06/23, With Invitation, Japanese
  25. Sero-prevalence of hepatitis B surface antigen among 5-7 years old children and their mothers in Cambodia by nationwide multi-stage stratified random sampling strategy , Tanaka J, Woodring J, Vichit O, Wasley A, Bunsoth M, Nagashima S, Yamamoto C, Chuon C, Ko K, Md Hossain MS, 53rd the international liver congress 2018 (EASL), 2018/04/12, With Invitation, English
  26. HBV prevalence estimated by nationwide survey in Cambodia, Tanaka J, ANRS Cambodian site scientific days, 2018/01/23, With Invitation, English
  27. HBV prevalence in Vietnam, United States-Japan Cooperative Medical Science Program (USJCMSP) 20th International Conference on Emerging Infectious Diseases, 2018/01/10, With Invitation, English
  28. Economic impact of HCV treatment-Japan, 2015-2030, Tanaka J, AASLD THE LIVER MEETING 2017, 2017/10/20, Without Invitation, English
  29. Economic impact of HCV treatment-Japan, 2015-2030, Tanaka J, Estes C, Razavi H, 24th International Symposium on Hepatitis C virus and Related Viruses(HCV2017), 2017/09/25, Without Invitation, English
  30. Epidemiology of HBV and HCV infections from the viewpoints of eradication of liver cancer, Tanaka J, APASL(Asian Pacific Association for the Study of the Liver-Single Topic Conference 2017), 2017/04/11, With Invitation, English
  31. HBV screening, Further improvement of blood safety. -based on the knowledge deduced from the results on analysis of the donor's sera positive for HBV DNA by NAT as well as the results of experimental HBV infection to Chimpanzees-, Tanaka J, Yoshizawa H, SoGAT XVIII, 2005/05, Without Invitation, English

Social Activities

Other Social Contributions

  1. A grateful America Chamber of Commerce in Japan (ACCJ) Healthcare Committee & Pharmaceuticals Subcommittee Meeting, topics on hepatitis C and hepatitis B from an epidemiological viewpoint, 2012/07/27, 2012/07/27, Lecturer, Lecture
  2. The 28th Meeting of the Technical Advisory Group on Immunization and Vaccine-Preventable Diseases in the Western Pacific Region, 2019/06/18
  3. EASL The Hepatology Day in Uzbekistan within the framework of the Conference "Topical aspects of viral infections", 2018/02, Others
  4. 20th International Conference on Emerging Infectious Disease(EID) in the Pacific Rim, Shenzhen, China, 2018/01, Lecturer
  5. ANRS Cambodian site scientific days in Cambodia, 2018/01, Lecturer
  6. IPFA/PEI 24th Inernational Workshop on Surveillance and Screening of Blood-borne Pathogens,Zagreb,Croatia, 2017/05, Panelist